Latest filing published 24 May 2023 for Glycorex Transplantation, €3,721.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Johan Lavén: trading record in brief
Johan Lavén is a declared insider of Glycorex Transplantation, with filings sourced from Finansinspektionen. The record holds 4 filings, for trades running from 9 December 2022 to 24 May 2023.
The open-market record is one-sided, with 4 purchases worth €16k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2023: 3 purchases and no sales on the market.
Half of the purchases are above €3,667 and half below. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The latest filing, published on 24 May 2023, reports an open-market purchase of €3,721 in Glycorex Transplantation. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Johan Lavén
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,000 shares@ SEK 3.3023.5% of flowAktieISIN SE0000524530FI:csv-3556f3eb0660c23f00c3Canonical exit: 22 Aug 2023 (T+90)
- 5,000 shares@ SEK 4.0011.3% of flowAktieISIN SE0000524530FI:csv-284680fca4d15b639ce3Canonical exit: 22 Jun 2023 (T+90)
- 10,000 shares@ SEK 4.0322.8% of flowAktieISIN SE0000524530FI:csv-d87550e926bdf6c74e79Canonical exit: 4 Apr 2023 (T+90)
- 17,000 shares@ SEK 4.3142.4% of flowAktieISIN SE0000524530FI:csv-79cc878d1cba1b4b52e7Canonical exit: 9 Mar 2023 (T+90)
4 of 4 declarations